Home > PE Ratio > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of KWALITY PHARMACEUTICALS is 26.75.

Share Price ₹1,453.7Feb 19,2026
Market Cap ₹1,511.8 Cr
Earnings-TTM₹56.5 CrTTM-Consolidated Results
Price/Earnings26.75xCalculated as Market Cap/Earnings
Explore Stock Analytics
AD     Remove this Ad
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of KWALITY PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of KWALITY PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,511.8 Cr] as on Feb 19,2026

(/) Earnings [ ₹56.5 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 26.75x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay 26.75 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KWALITY PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of KWALITY PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of KWALITY PHARMACEUTICALS


PE Ratio Performance Analysis for KWALITY PHARMACEUTICALS

- KWALITY PHARMACEUTICALS 's latest p/e ratio is 26.75x.

- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 13.16x.

- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 16.47x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 22.63x.

- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 3.84x.


How does KWALITY PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
KWALITY PHARMACEUTICALS 56.5126.751,511.8
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4037.36411,054.0
DIVIS LABORATORIES LTD2,479.0067.40167,075.0
CIPLA LTD4,544.7023.62107,358.0
TORRENT PHARMACEUTICALS LTD2,272.0062.90142,904.0
DR REDDYS LABORATORIES LTD5,508.7019.39106,813.0
MANKIND PHARMA LTD1,796.6546.8284,111.1
ZYDUS LIFESCIENCES LTD4,933.9018.4090,787.5
LUPIN LTD4,669.1821.81101,848.0
AUROBINDO PHARMA LTD3,513.2019.4468,287.8
ABBOTT INDIA LTD1,524.1336.7956,075.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KWALITY PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.40x
Max industry PE 67.40x
Median industry PE 26.75x
Average industry PE 34.61x



You may also like the below Video Courses